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Abstract. Plasmodium falciparum gametocytes develop over 9–12 days while sequestered in deep tissues. On
emergence into the bloodstream, they circulate for varied amounts of time during which certain host factors might
inﬂuence their further development. We aimed to evaluate the potential association of patient clinical parameters with
gametocyte development andcarriage via in vivomethods. Seventy-twopatientswere enrolled from three hospitals in the
Volta region of Ghana in 2016. Clinical parameters were documented for all patients, and gametocyte prevalence by
microscopywasestimatedat 12.5%.BymeasuringRNA transcripts representing twodistinct gametocyte developmental
stages using reverse transcriptase quantitative polymerase chain reaction (RT-qPCR), we obtained a more precise
estimate of gametocyte carriage while also inferring gametocyte maturation. Fifty-three percent of the study participants
harbored parasites expressing transcripts of the immature gametocyte-speciﬁc gene (PF3D7_1477700), whereas 36% har-
bored PF3D7_1438800RNA-positive parasites, which is enriched inmid andmature gametocytes, suggesting the presence of
more immaturestages.Linear logistic regressionshowedthatpatientsolder than5yearsbut less than16yearsweremore likely to
carry gametocytes expressing both PF3D7_1477700 and PF3D7_1438800 compared with younger participants, and game-
tocytemia was more likely in mildly anemic individuals compared with those with severe/moderate anemia. These data provide
further evidence that a greater number of malaria patients harbor gametocytes than typically estimated by microscopy and
suggest a possible association between age, fever, anemia, and gametocytemia.
INTRODUCTION
Malaria is one of the most important infectious parasitic
diseases and was responsible for approximately 445,000
deaths globally from more than 216 million clinical cases in
2016.1 Among the different malaria parasites, P. falciparum is
the most virulent and accounts for most malaria-associated
mortality and morbidity in sub-Saharan Africa. In the Volta
region of Ghana, P. falciparum is the main cause of malaria,
and it is the responsible agent in 98% of hospitalized malaria
patients.2 The parasites are transmitted through the bite of
infected anopheline mosquitoes, with the pathology resulting
from the asexual replication of parasites within circulating red
blood cells, leading to anemia, disrupted blood ﬂow, and in-
ﬂammation that can be lethal if untreated. The transmission of
malaria from humans to mosquitoes is mediated by special-
ized sexual stages called gametocytes, which are derived
from asexual parasites. Gametocytes of P. falciparum have a
prolonged development of 9–12 days, maturing through ﬁve
distinct morphological and metabolic stages. In vivo, stages
I–IV are sequestered in the spleen and the hematopoietic
system and the extravascular space of the bone marrow3–6
whereas mature stage V gametocytes are present in pe-
ripheral circulation. Mature gametocytes circulate in the
bloodstream for a varied number of days ranging 1.3–
22.2 days, during which period they are available to biting
mosquitoes.7–10 In vitro, gametocytes can persist for about
16–32 days.9
A number of host factors have been linked to gametocyte
development and appearance in the presence of treatment.
Age, hematocrit, hemoglobin genotype, fever, and duration of
symptoms have all been associated with gametocytemia in
treated patients.11–13 In addition, drug treatment and host
immune responses have been linked with different levels of
gametocytemia.14–16 In in vitro experiments, speciﬁc parasite
strains have been associated with different levels of gameto-
cyteproduction and the serumused in gametocyte cultivation,
suggesting the involvement of parasite genetic factors and
host immune factors.17 In addition, microvesicles have been
shown to mediate communication between malaria para-
sites, and the abundance of these vesicles correlated with
high peripheral blood parasitemia18 and stimulation of ga-
metocytes in vitro.19,20 Very recently, levels of the host serum
factor lysophosphatidylcholine were shown to inﬂuence rates
of sexual differentiation,21 providing additional evidence for
the inﬂuence of host factors on parasite development.
The involvement of certain parasite genes in gametocyte
commitment and production has been demonstrated. Notably,
the expression of the P. falciparum gametocyte development 1
protein has been shown to be critical for gametocyte produc-
tion. Available evidence localizes this protein to the nucleus,
where itmight be involved in regulating gametocyte production
pathways.22,23 In addition, the transcription factor AP2-G has
been identiﬁed as a master regulator for sexual development,
and its expression is controlled epigenetically through the in-
corporation of the silencing histone mark, histone 3 lysine 9
trimethylation (H3K9me3), at the ap2-g locus.24,25
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Although both the parasite and host factors are involved in
regulating sexual differentiation and development, it is not
known how these factors directly affect gametocyte pro-
duction in vivo as most human studies have been in treated
individuals. It is known that a variable percentage of asexual
parasites develop into gametocytes, but how this is de-
termined and regulated in vivo is not clearly understood, as
early gametocyte markers have mainly been deployed in
studies of cultured P. falciparum.9,10,22 In this study, we
measured transcripts from two different gametocyte-speciﬁc
genes as indicators of early and late stages of sexual devel-
opment, respectively, and related gene expression to patient
clinical parameters. As previously described,26 these parasite
stage-speciﬁc genes were selected based on their stage
speciﬁcity and transcript abundance. Genes representing
three developmental stages of P. falciparum were used: ring
stage asexual trophozoites (TR, PF3D7_0501300), early-mid
developing gametocytes (DG, PF3D7_1477700), andmid-late
maturing gametocytes (MG, PF3D7_1438800) to enable the
assessment of the development of gametocytes in malaria
patients. The ring stage marker, TR, is a skeleton-binding
protein associated with the infected erythrocyte skeleton that
is highly expressed in ring stage TR compared with other life
cycle stages. The early-mid gametocyte marker, DG, is an
exported protein with a Plasmodium helical interspersed
subtelomeric A domain whereas the mid-early gametocyte
marker, MG, is a conserved protein with an OST-HTH–
associated domain. The functions of DG and MG are un-
known, but DG is thought to be enriched speciﬁcally in
asexual stages committed toward the sexual pathway22
whereas MG is highly expressed in gametocytes stages
III–V.27 All three genes are intron-containing markers that
enables the avoidance of genomic DNA ampliﬁcation, by
contrast to the established immature and mature gameto-
cyte markers Pfs16 and Pfs25. In addition, the frequency of
gametocytemia in infections carrying gene variants asso-
ciated with quinolone- and antifolate- drug resistance was
assessed. The ﬁndings will inform the design of new
strategies to more accurately dissect gametocyte pro-
duction in patients and allow amore detailed analysis of the
mechanisms involved in gametocyte maturation, which
could lead to the development of transmission-blocking
interventions.
MATERIALS AND METHODS
Ethics statement. The study obtained ethical clearance
from the Ghana Health Service Ethics Review Committee in
Accra (ID No: GHS-ERC 03/05/15) and the internal review
board at the Weill Cornell Medical College in New York
(IRB#1508016447). In addition, written informed consent and
accent, in the case of children between 10 and 14 years, were
obtained from individuals/parents/guardians before enroll-
ment into the study. The study procedures, risks, and beneﬁts
were explained to all study participants and caregivers. Pos-
itive asexual parasites and gametocyte control samples for
reverse transcriptase quantitative polymerase chain reactions
were obtained from culture-adapted parasite isolates from
among the study samples.
Study area. This was a hospital-based study conducted
between June and July 2016 in Ho in the Volta region, located
in the southeastern part of Ghana where it borders Togo. The
study area, environment, and malaria situation have been
previously described.2 Plasmodium falciparum is responsible
for almost all clinical malaria in this area. We had previously
found that Plasmodium malariae was PCR-detectable in 2%
of infections (5/211) in this area, and that all but one were
coinfectionswithP. falciparum.2 To date, noPlasmodiumovale
has been detected. The transmission of malaria in this area is
variable but usually peaks one month after the start of each of
the two rainy seasons, which take place from April to July and
from September to November. The entomological inoculation
rate for a nearby town, Hohoe, was estimated to be 65 in-
fectious bites per person per year.28
Patients and sample collection. Patients of all ages at-
tending outpatient clinics at the Ho Polyclinic, the Ho Munic-
ipal Hospital, and Volta Regional Hospital were screened for
malaria by rapid diagnostic tests (RDT) (StandardDiagnostics,
Korea) and microscopy using ﬁnger-prick blood. Rapid di-
agnostic tests or microscopy-positive individuals, who gave
their consent, were enrolled into the study to investigate the
human host and parasite factors modulating the gametocyte
development. Up to 5 mL of venous blood was collected
in heparinized tubes from all participants for slide prepara-
tion, RNA preservation in Trizol (Invitrogen, Carlsbad, CA),
parasite culture, and plasma separation. An additional
blood sample of approximately 0.5 mL was collected in an
ethylenediaminetetraacetic acid tube for the determination
of hematological parameters using a Sysmex hematology
analyzer (Sysmex America, Irvine, CA). Brieﬂy, plasma from
venous blood was separated by centrifuging at 2,000 rpm for
10 minutes. The resulting parasite material was used for cryo-
preservation, parasite culture, and parasite nucleic acid (RNA)
preservation in Trizol and blood smears. Once samples were
collected, participants were assisted to follow hospital pro-
cedures for disease management with no subsequent follow-
up by us. Patients who had other illnesses in addition to
malaria or had taken antimalarials in the preceding 14 days
were excluded from the study.
Assessment of asexual parasitemia and gametocytemia.
Microscopy. Thin and thick smears were stained with 10%
Giemsa for microscopic diagnosis and subsequent de-
termination of parasitemia. Thin blood smears were ﬁxed with
methanol before Giemsa staining. Estimation of parasite den-
sitieswascarriedout by countingasexual parasites against 200
leukocytes whereas counting gametocytes against 500 leuko-
cytes. Both parasite counts were converted to parasites per
microliter by assuming a standard leukocyte count of 8,000
leukocytes in onemicroliter of blood, as already described.29,30
The slides were declared negative if no asexual parasites were
seen after the examination of 100 microscopic ﬁelds.
Reverse transcriptase quantitative PCR.RNA extraction,
DNase digests, and reverse transcription. Fifty microliters of
whole blood samples obtained from patients were stored in
500 μL of Trizol at −80C until RNA extraction. Total RNA from
the samples was ﬁrst extracted using the phenol–chloroform
method, aspreviously described,31 and thenpuriﬁedusing the
AllPrep DNA/RNA Mini Kit (QIAGEN, Hilden, Germany) fol-
lowing the instructions from the manufacturer. The resulting
RNAwas treatedwith DNase (Invitrogen) and stored at −80C.
The SuperScript III First Strand Synthesis kit from Invitrogen
was then used to synthesize the ﬁrst-strand cDNA.
Quantitative PCR assay. Ampliﬁcation and quantiﬁcation
of stage-speciﬁc gene transcripts (rings PF3D7_0501300,
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early-mid gametocytes PF3D7_1477700, and mid-late ga-
metocytes PF3D7_1438800)26 were performed using the
QuantStudio5 (Applied Biosystems, Foster City, CA). Pre-
viously reported primer sets that target genes representing the
aforementioned stageswere used.26 All reactionswere run in a
total volume of 10 μL containing 1X PerfeCTa SYBR Green
SuperMix, 0.5 μM of each of the forward and the reverse pri-
mers, and 2 μL of the target cDNA. The thermal proﬁle for the
reactions included 10 minutes at 95C, 40 cycles of 15 sec-
onds at 95C and 1 minute at 60C. The speciﬁcities of the
resulting products were analyzed using the dissociation curve
and experiments with nonspeciﬁc products were repeated. All
samples were run in triplicate and the mean Ct values were
determined. Parasite-stage positivity was based on the ab-
sence or presence of the stage-speciﬁc RNA transcripts de-
termined by the Ct values £ 35. A positive control RNA sample
(GDVRH008) was obtained from a culture-adapted isolate of
knownasexual andgametocyte stagecompositiondetermined
bymicroscopy. The control isolate, GDVRH008, was chosen
because the patient was gametocyte-positive by micros-
copy and was readily inducible to produce gametocytes
in vitro. This samplewaspositive also for all three stages of the
parasite by RT-qPCR and at presentation had a gametocyte
density of 16 parasites per microliter whereas the asexual par-
asite density was 26,160 parasites permicroliter bymicroscopy.
Detection of single nucleotide polymorphisms (SNPs) in
patient isolates. Genomic DNA extraction, nested PCR, and
restriction enzyme digestion. The presence of antimalarial
drug–associated SNPs in the clinical isolates was determined
using PCR–restriction fragment length polymorphism. Brieﬂy,
DNA was extracted from all the samples using the AllPrep®
DNA/RNA Mini Kit (QIAGEN) following the manufacturer’s in-
structions and then stored at –20C. Both the outer and the
nested PCRs were performed to amplify genomic regions that
ﬂank point mutations in the P. falciparum chloroquine re-
sistance transporter gene (pfcrt) at position K76T;P. falciparum
multidrug resistance gene one (pfmdr1) at positions N86Y and
Y184F; P. falciparum dihydrofolate reductase gene (pfdhfr) at
positions N51I, C59R, and S108N; and P. falciparum dihy-
dropteroate synthetase (pfdhps) gene at positions A437G and
K540E that have been implicated in antimalarial drug re-
sistance. All reactionswereperformed ina total volumeof 25μL
containing 1X of Maxima Hot Start Green PCR Master Mix
(Thermo Scientiﬁc, Waltham, MA) and 200 nM of each of the
forward and reverse primers. A volume of 0.5 μL of the initial
PCR product was used as template DNA in the nested PCR
and, 5μLof the resultingproductwas separatedonanethidium
bromide–stained 2% agarose gel before restriction digestion.
PCR primer sets and cycling conditions for pfcrt and pfmdr1
were performed as previously reported32 whereas primers and
conditions for pfdhfr and pfdhps also followed procedures
already established.33 Using SNP-speciﬁc endonucleases
(obtained from Thermo Scientiﬁc), 5 μL of the nested PCR
product for each of the four genes was digested in a ﬁnal
volume of 15 μL. The restriction digest products were sepa-
ratedon an ethidiumbromide–stained 2%agarose gel and the
resulting gel was processed using the Amersham Imager 600
(General Electric, Boston, MA). Laboratory-adapted strains of
P. falciparum of known genotypes were used as controls for
the wild-type and the mutant alleles.
Data analysis. Descriptive statistics was calculated using
Stata version 14.2 (College Station, TX) and Microsoft Excel
for determining means, percentages, standard deviation, and
plotting of graphs. Age and hemoglobin levels of patients were
categorized into four groups each (< 5, 5–9, 10–16, and >
16 years; and severe (< 8 g/dL), moderate (8–11 g/dL), mild
(11–13 g/dL), and non-anemic (> 13 g/dL, respectively). For the
purpose of logistic regression analysis, the severe anemia and
moderate anemia groupswere combined. These could therefore
be considered as continuous or categorical variables depending
on the analysis. The association between two continuous
variables was assessed using Spearman’s rank correlation
coefﬁcient, whereas continuous and binary variables were
assessed using Wilcoxon rank sum test. The linear logistic re-
gression model was used to determine the association be-
tween age, hemoglobin, fever, and gametocyte carriage (MG).
RESULTS
Gametocyte carriage by microscopy. A total of 72 (Volta
Region Hospital = 10, Ho Polyclinic = 16, and Ho Municipal
Hospital = 46) RDT-positive individuals were enrolled and in-
cluded during the 2-month study period (Table 1). Fever, tem-
perature > 37.5C, was recorded in 65% of all participants
examined. Asexual parasite prevalence by microscopy was
91.67%(66/72) (Table 1).Gametocyteprevalencebymicroscopy
was 12.5% (9/72) (Table 1). The study participants were some-
what evenly distributed among the different age categories, and
all gametocyte carriers were either moderately or mildly anemic.
Thegeometricmeanasexualparasitedensitybymicroscopywas
8,037.7 (95% conﬁdence intervals: 5,075.9–12,727.8) para-
sites/μL whereas the geometric mean gametocyte density was
37.8 (95%CI: 24.7–58.0) parasites/μL (Table 1).
Gametocyte carriage by RT-qPCR. Parasite stage-
speciﬁc RT-qPCR was used to determine the presence
of TR (PF3D7_0501300), DG (PF3D7_1477700), and MG
(PF3D7_1438800) transcripts in each infection. Transcripts of
TABLE 1
Characteristics of patients at enrollment were as follows: Anemia
was deﬁned as severe (< 8 g/dL), moderate (8–11 g/dL), mild
(11–13 g/dL), and non-anemic (> 13 g/dL)
Parameter Value
No 72
Female: male 41:31
Age in years, median (range) 13 (1–76)
Axillary temperature, median in C
(range)
37.3 (36–40.6)
Fever, % (n/N) 65 (47/72)
Hemoglobin level, median in g/dL
(range)
11.4 (3.4–16.2)
Microscopy
Asexual parasite prevalence, % (n/N) 91.67 (66/72)
Geometric mean asexual parasite
density/μL (95% CI)
8,037.7 (5,075.9–12,727.8)
Gametocyte prevalence, % (n/N) 12.5 (9/72)
Geometric mean gametocyte
density/μL (95% CI)
37.8 (24.7–58.0)
Reverse transcriptase quantitative PCR
PF3D7_0501300 RNA-positive ring
stage prevalence, % (n/N)
100 (72/72)
PF3D7_1477700 RNA-positive
early-mid gametocyte prevalence,
% (n/N)
52.8 (38/72)
PF3D7_1438800 RNA-positive
mid-late gametocyte prevalence
% (n/N)
36.1 (26/72)
Fever was deﬁned as temperature > 37.5C.
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the TR gene26 were present in all individuals, including the 6
RDT-positive individuals who were negative for parasites by
microscopy. The DG transcript was detected in 53% of indi-
viduals, whereas the MG transcript was detected in 36%
(Figure 1). All nine individuals with detectable gametocytes by
microscopy were positive for MG transcripts by RT-qPCR
assay giving us a 100% speciﬁcity for microscopy but a sig-
niﬁcantly lower sensitivity than for RT-qPCR. Interestingly,
four of the nine individuals with microscopically detectable
gametocytes had no RT-qPCR signal for DG transcripts. The
participants who were positive for either DG, MG or both
transcripts (22/72) displayed mild or moderate anemia (32/38)
but were evenly distributed betweenmale and female patients
(Table 2). The presence of the DG transcript is unexpected as
DG are not found in the peripheral circulation and so should
not havebeen captured in ﬁnger-prick sampling.However, the
DG and MG transcripts have been previously characterized
during gametocyte maturation in vitro,9,34 and it is unknown
whether circulating sexually committed TR may also express
the DG transcript in vivo.
Prevalence of antimalarial (SNPs). The prevalence of
known drug resistance–associated gene mutations in the
parasite isolates was determined and related to gametocyte
carriage in the participants. No isolate was found to contain
the dhps-540mutant allele, but the IRN triple mutant of pfdhfr
was the predominant genotype at this locus (Figure 2).
Sixty percent (3/5) and 48% (19/31) of the participants that
harbored mutations in mdr1-86 and mdr1-184, respectively,
were positive for DG as determined by RT-qPCR. Similar ob-
servations were made when the prevalence of mdr1-86 and
mdr1-184mutations were compared with individuals harbor-
ing mature gametocytes (Table 3). Fifty-seven percent of the
participants with the mutation dhps-437 had developing and
mature gametocytes. All three mutations of dhfr tested were
quite high, dhfr-51, dhfr-59, and dhfr-108, 91.07% (51/56),
85.96% (49/57), and 91.07% (51/56), respectively (Figure 2).
Because of the high prevalence of the respective dhfr
mutations, between 40% and 60% of participants expressing
the different gametocyte markers had the mutations as seen
already for dhps (Table 3).
Age, hemoglobin levels, fever, and gametocytemia.
Anemia was very common among our study participants.
Based on theWorldHealth Organization deﬁnition of anemia,35
we found that 87.5% of all our study participants had various
degrees of anemia ranging from severe to mild anemia. Based
on a linear logistic regression model, we observed that study
participants between the ages of ﬁve (odds ratio [OR] = 4.50,
95% CI: 0.99–21.11) and 16 (OR = 5.00, 95% CI: 1.02–24.27)
(Table 4) were more likely to carry MG transcripts compared
with those younger than 5 years or older than 16 years. More-
over, mild anemia (OR = 1.88 [95% CI: 0.69–5.11] and no
anemia (OR=2.77 [95%CI: 0.56–13.76] (Table 4)werepossible
predictors of gametocytemia compared with severely anemic
participants. The prevalence of gametocytemia was less likely
in patients with fever (OR = 0.74 [95% CI: 0.28–1.97] as com-
pared with those without fever (Table 4). When the early-mid
gametocyte marker was used, only age was found to be as-
sociated with gametocytemia (5–9 years: OR = 3.27 CI:
0.65–16.38 and 10–16 years: OR = 2.05 CI: 0.44–9.58).
DISCUSSION
The present study identiﬁed age, fever, and hemoglobin
levels to be associated with carriage of MG transcripts, which
may be a useful indicator of gametocyte carriage in malaria
patients. Alleles associated with resistance to various anti-
malarial drugs were very common, including among partici-
pants with RT-qPCR evidence of gametocyte carriage. We
also found higher estimates of gametocyte carriage by RT-
qPCR than microscopy and showed that some individuals
with DGmRNAdid not have detectableMGmRNA levels. This
was surprising because DGmRNA is assumed to indicate the
presence of immature gametocytes, which are sequestered in
tissues such as the bone marrow and therefore should not be
FIGURE 1. Proportion of patients with PF3D7_1477700 and PF3D7_1438800 transcript-positive gametocytes as detected by stage-speciﬁc
reverse transcriptase quantitative PCR: More than half of the participants were positive for PF3D7_1477700mRNA, but not all these were positive
for PF3D7_1438800 mRNA levels suggesting the presence of early maturing gametocytes. An even smaller proportion was positive for both
PF3D7_1477700 and PF3D7_1438800 transcripts. This ﬁgure appears in color at www.ajtmh.org.
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detected in samples from theperipheral circulationofpatients.
However, in vitro studies have shown that DG’ transcripts can
possibly come from sexually committed TR as they begin the
asexual–sexual stage transition.22 Therefore, these tran-
scripts could indeed represent asexual parasites from the
gametocyte commitment cycle which occurs before sexual-
stage induction and differentiation. A longitudinal study is
required to investigate the possibility of sexually committed
TR in the peripheral circulation and their potential disappear-
ance through sequestration.
This study was able to identify 36% of participants as car-
riers of mature gametocytes through the detection of MG
transcripts. In comparison, only 12.5% of individuals were
identiﬁed as gametocyte carriers by microscopy. Several
studies using molecular tools similarly detected higher levels
of submicroscopic densities of gametocytes when compared
with microscopy, and the gametocytes detected were even
shown to establish infection in mosquitoes.36–38 In most of
these studies, higher gametocyte densities were observed
after drug treatment compared with the time of clinical pre-
sentation. artemisinin-based therapies reduce submicro-
scopic gametocytemia but do not completely prevent
posttreatment transmission to mosquitoes in other studies.39
Our study participants were not followed up after treatment
and itwasnot possible to estimate the level of submicroscopic
gametocytemia following treatment. However, it is evident
that microscopy heavily underestimates the proportion of in-
dividuals potentially capable of transmitting gametocytes to
mosquitoes.
Many factors are considered to inﬂuence commitment and
production of gametocytes including genetic switching22,23
and environmental factors.40–42 Supplementation of serum,
regardless of the malaria infection status of donors, has been
shown to induce and improve gametocyte yields in in vitro
gametocyte cultures.9,43 Clinical parameters such as age, the
absence of fever, and hemoglobin levels have been previously
shown to inﬂuence thedegreeof gametocytemia in individuals
treated with different types of antimalarials.11,44–46 We found
no strong relationship between age, hemoglobin levels, or
fever with gametocytemia, but given our small sample size,
these relationships will be investigated in larger studies in the
future. However, the association we see with higher gameto-
cyte prevalence in slightly older participants could be due to
the level of clinical immunity they have acquired. Clinical
TABLE 2
Clinical, demographic parameters and the composition of gametocytes as measured by reverse transcriptase quantitative PCR
Parameter Early-mid gametocytes (N = 38) % Early-mid gametocytes Mid-late gametocytes (N = 26) % Mid-late gametocytes
Gender M 18 47 13 50
F 20 53 13 50
Fever Yes 15 39 7 27
No 23 63 19 73
Age < 5 years 6 16 6 23
5–10 years 12 32 8 31
10–16 years 9 24 7 27
> 16 years 11 29 5 19
Anemia Moderate 16 42 11 42
Mild 16 42 11 42
Non-anemic 6 16 4 15
M represents males whereas F represents females.
FIGURE 2. Prevalence of antimalarial drug resistance-associated single nucleotide polymorphisms (SNPs): Each bar represents the proportion of
thesamples that display themutant (blue)orwild-type (orange) aminoacidat thepositiondesignatedbelow thebar.BesidesPlasmodiumfalciparum
chloroquine resistance transporter (pfcrt)-76 and P. falciparummultidrug resistance gene one (Pfmdr1)-86 with mutations less than 10%, all other
SNPs that we investigated were found to be saturated. No mutation in dhps-540 was found. This ﬁgure appears in color at www.ajtmh.org.
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immunity could play several roles including maintenance
of low-grade asexual parasitemia and constant modulation of
sexual development. Hemolysis of erythrocytes because of
either highburdenof parasitemia or effects of drugs havebeen
suggested to trigger gametocyte production, but the degree
of hemolysis was not investigated.47 This is consistent with
our observation of gametocytemia in mildly anemic partici-
pants and agrees with other ﬁndings on the clinical correlates
of gametocytemia.46 The high odds ratios for non-anemic,
fever-free individuals is interesting and may suggest high
prevalence of gametocytes in asymptomatics as already
shown in other studies.46
Additional factors associated with patient gametocyte
carriage include slow parasite clearance and carriage of drug
resistance genotypes/alleles/polymorphisms.48,49 We found
very high antimalarial-associated SNPs in some isolates but
not others. Higher levels of dhps and dhfr alleles, which are
associated with sulfadoxine–pyrimethamine (SP) resistance,
wereobserved, but parasites carrying the crucialpfdhps-540E
allelewere absent among our study participants. In Ghana, SP
is used for intermittent preventive treatment of malaria in
pregnant women, which could contribute to the moder-
ate levels of predicted SP resistance we and others have
observed.50 On the contrary, low levels of chloroquine
resistance–associated alleles were detected and may be an
indication of the parasite population reverting to the sensitive
genotype on removal of chloroquine from the market, as has
been seen in other places.51 We however, did not ﬁnd any
signiﬁcant correlation of the presence of these SNPs and
gametocyte-speciﬁc transcripts in our patients probably be-
cause of the fact that most of the SNPs had a very high
prevalence, and so our study was underpowered to test for
such associations.
CONCLUSION
This study provides further evidence of the relationship
between hemoglobin levels and the age of malaria patients
and gametocyte carriage. In addition, it demonstrates an
abundance of submicroscopic gametocytes as measured by
RT-qPCR in untreated but sick populations providing ample
opportunity for malaria transmission before treatment. The
possibility that DG transcripts are present in sexually com-
mitted TR should be investigated in future studies.
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